Study of Telaprevir in Subjects With Hepatic Impairment
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and pharmacokinetics of Telaprevir
following administration of multiple oral doses to subjects with moderate and severe hepatic
impairment.